Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death

Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death

Abstract The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy. Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is characterized by the emission of damage-associated molecular patterns (DAMPs) from dying cells. This emission can trigger eff...

Full description

Bibliographic Details
Main Authors: Victoria D. Turubanova, Tatiana A. Mishchenko, Irina V. Balalaeva, Iuliia Efimova, Nina N. Peskova, Larisa G. Klapshina, Svetlana A. Lermontova, Claus Bachert, Olga Krysko, Maria V. Vedunova, Dmitri V. Krysko
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-86354-4

Internet

https://doi.org/10.1038/s41598-021-86354-4

Similar Items